Racial and socioeconomic disparities in survival among patients with metastatic non-small cell lung cancer.

ABSTRACT:

Background

Immune checkpoint inhibitors have profoundly impacted survival among patients with metastatic non-small cell lung cancer. However, population-based studies evaluating this impact on survival by race and socioeconomic factors are lacking.

Methods

We used the Surveillance, Epidemiology, and End Results Program-Medicare database to identify patients with metastatic non-small cell lung cancer diagnosed between 2015 and 2019. The primary study outcomes were the receipt of an immune checkpoint inhibitor and overall survival. χ2 tests and logistic regression were used to identify demographic factors associated with receipt of immune checkpoint inhibitors. The Kaplan-Meier method was used to calculate 2-year overall survival rates, and log-rank tests were used to compare

SUBMITTER: Uprety D 

PROVIDER: S-EPMC11461161 | biostudies-literature | 2024 Oct

REPOSITORIES: biostudies-literature